Skip to Main Content

Author Details

Gianluca Trifirò
2004
245
42
PMIDPaper TitleJournal TitlePublished Year
37219785Communicating for the Safe Use of Medicines: Progress and Directions for the 2020s Promoted by the Special Interest Group of the International Society of Pharmacovigilance.2023
36128628Neonatal withdrawal syndrome following in utero exposure to antidepressants: a disproportionality analysis of VigiBase, the WHO spontaneous reporting database.Psychological Medicine2023
37891814Pharmacological Therapies of Spinal Muscular Atrophy: A Narrative Review of Preclinical, Clinical-Experimental, and Real-World Evidence.2023
37795368Global incidence and prevalence of differentiated thyroid cancer in childhood: systematic review and meta-analysis.2023
37714536Is antidepressant use a concern for patients with COPD?2023
37555938Anaphylaxis due to antiallergic and antiasthmatic biologics.2023
37148526Exploring the Use of Monoclonal Antibodies and Antiviral Therapies for Early Treatment of COVID-19 Outpatients in a Real-World Setting: A Nationwide Study from England and Italy.2023
37024736Cohort Event Monitoring of Adverse Reactions to COVID-19 Vaccines in Seven European Countries: Pooled Results on First Dose.Drug Saf2023
37463655Suspected adverse reactions to medications and food supplements containing Serenoa repens: A worldwide analysis of pharmacovigilance and phytovigilance spontaneous reports.2023
36882619Acid sphingomyelinase deficiency (ASMD): addressing knowledge gaps in unmet needs and patient journey in Italy-a Delphi consensus.2023
36936062Testing of Coding Algorithms for Inflammatory Bowel Disease Identification, as Indication for Use of Biological Drugs, Using a Claims Database from Southern Italy.2023
37243676An overview of methodological flaws of real-world studies investigating drug safety in the post-marketing setting.2023
36790561Is PEGylation of Drugs Associated with Hypersensitivity Reactions? An Analysis of the Italian National Spontaneous Adverse Drug Reaction Reporting System.2023
36534353Real-world patient characteristics and use of disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis: a cross-national study.2023
36725094Methodology of the brodalumab assessment of hazards: a multicentre observational safety (BRAHMS) study.2023
37484864Hidradenitis suppurativa and psoriasis: the odd couple.2023
35075918Assessment of intravitreal anti-VEGF drugs and dexamethasone for retinal diseases in real world setting: A multi-centre prospective study from Southern Italy.European Journal of Ophthalmology2022
35707398Time to Treatment Intensification in Patients Receiving DPP4 Inhibitors Sulfonylureas as the First Add-On to Metformin Monotherapy: A Retrospective Cohort Study.Frontiers in Pharmacology2022
35450044Efficacy of Systemic Biologic Drugs in Pediatric Psoriasis: Evidence From Five Selected Randomized Clinical Trials.Frontiers in Pharmacology2022
35959441Real-world evidence (RWE): A challenge for regulatory agencies discussion of the RWE conference with the network of the european medicine agencies, patients, and experts.Frontiers in Pharmacology2022
35900992Postmarketing active surveillance of myocarditis and pericarditis following vaccination with COVID-19 mRNA vaccines in persons aged 12 to 39 years in Italy: A multi-database, self-controlled case series study.PLoS Medicine2022
35829913Post-Marketing Surveillance of CAR-T-Cell Therapies: Analysis of the FDA Adverse Event Reporting System (FAERS) Database.Drug Safety2022
35696066Allergic Reactions to COVID-19 Vaccines: Risk Factors, Frequency, Mechanisms and Management.BioDrugs2022
36151305Development and testing of diagnostic algorithms to identify patients with acromegaly in Southern Italian claims databases.Scientific Reports2022
35862782Donor Simvastatin Treatment Is Safe and Might Improve Outcomes After Liver Transplantation: A Randomized Clinical Trial.Transplantation2022
36400895Withdrawal Syndrome Following Discontinuation of 28 Antidepressants: Pharmacovigilance Analysis of 31,688 Reports from the WHO Spontaneous Reporting Database.Drug Safety2022
35852077[The role of real-world evidence for the study of rare diseases epidemiology and the post-marketing evaluation of orphan drugs.]Recenti Progressi in Medicina2022
34275763Drug-induced Urinary Retention: An Analysis of a National Spontaneous Adverse Drug Reaction Reporting Database.European Urology Focus2022
34304672Assessing intravitreal anti-VEGF drug safety using real-world data: methodological challenges in observational research.Expert Opinion on Drug Safety2022
35252257Orphan Drug Prices and Epidemiology of Rare Diseases: A Cross-Sectional Study in Italy in the Years 2014-2019.Frontiers in Medicine2022
35249211Italian guidelines on management of persons with multimorbidity and polypharmacy.Aging clinical and experimental research2022
34826340From Inception to ConcePTION: Genesis of a Network to Support Better Monitoring and Communication of Medication Safety During Pregnancy and Breastfeeding.Clin Pharmacol Ther2022
35092329Overview of the European post-authorisation study register post-authorization studies performed in Europe from September 2010 to December 2018.Pharmacoepidemiology and Drug Safety2022
34362214Are Patients with Psoriasis and Psoriatic Arthritis Undertreated? A Population-Based Study from Southern Italy.Journal of Clinical Medicine2021
32495965Safety profile of immune checkpoint inhibitors: An analysis of the Italian spontaneous reporting system database.British Journal of Clinical Pharmacology2021
33805899Comparison of Direct Oral Anticoagulant Use for the Treatment of Non-Valvular Atrial Fibrillation in Pivotal Clinical Trials vs. the Real-World Setting: A Population-Based Study from Southern Italy.Pharmaceuticals2021
33856453Risk of coronavirus disease 2019 hospitalization and mortality in rheumatic patients treated with hydroxychloroquine or other conventional disease-modifying anti-rheumatic drugs in Italy.Rheumatology2021
33853534Chronic polytherapy after myocardial infarction: the trade-off between hospital and community-based providers in determining adherence to medication.BMC Cardiovascular Disorders2021
33747950Characteristics and Absolute Survival of Metastatic Colorectal Cancer Patients Treated With Biologics: A Real-World Data Analysis From Three European Countries.Frontiers in Oncology2021
34062938Kidney Disease in Diabetic Patients: From Pathophysiology to Pharmacological Aspects with a Focus on Therapeutic Inertia.International Journal of Molecular Sciences2021
33633039The value of the polypill in cardiovascular disease: an Italian multidisciplinary Delphi panel consensus.Journal of Cardiovascular Medicine2021
34061771Global epidemiology of acromegaly: a systematic review and meta-analysis.European Journal of Endocrinology2021
34057333Safety and potential interaction of immunosuppressive drugs for the treatment of inflammatory bowel disease in elderly patients.Minerva Gastroenterology2021
33527643Psoriasis and psoriasiform reactions secondary to immune checkpoint inhibitors.Dermatologic Therapy2021
34150655Incidence of Skin Cancer in Patients With Chronic Inflammatory Cutaneous Diseases on Targeted Therapies: A Systematic Review and Meta-Analysis of Observational Studies.Frontiers in Oncology2021
34358133Association of Influenza Vaccination and Prognosis in Patients Testing Positive to SARS-CoV-2 Swab Test: A Large-Scale Italian Multi-Database Cohort Study.Vaccines2021
32740955Point-of-Care test screening versus Case finding for paediatric coeliac disease: A pragmatic study in primary care.Acta Paediatrica, International Journal of Paediatrics2021
33067914Direct healthcare costs of chronic kidney disease management in Italy: What cost-savings can be achieved with higher biosimilar uptake and more appropriate use of erythropoiesis-stimulating agents?Pharmacoepidemiology and Drug Safety2021
34666689Anti-hypertensive drugs deprescribing: an updated systematic review of clinical trials.BMC Family Practice2021
34655434Anti-VEGF and Other Novel Therapies for Neovascular Age-Related Macular Degeneration: An Update.BioDrugs2021
  • 1 - 50 of 245

Recommended Authors

Collaborators

University Medical Center Utrecht
Co-authored papers 60
University of California los angeles
Co-authored papers 23
Erasmus Medical Center
Co-authored papers 22
Harvard Medical School
Co-authored papers 10
Erasmus University Medical Center
Co-authored papers 9
Erasmus University Medical Centre
Co-authored papers 4
Columbia University Irving Medical Center
Co-authored papers 3
Harvard Medical School
Co-authored papers 3
Harvard Medical School and Harvard Pilgrim Health Care Institute
Co-authored papers 3
Erasmus MC - University Medical Center Rotterdam
Co-authored papers 3
University of Aveiro
Co-authored papers 2
Division of Pharmacoepidemiology, Brigham & Women's Hospital, Harvard Medical School
Co-authored papers 2
INSERM CIC-P 1, Bordeaux PharmacoEpi, Universite de Bordeaux
Co-authored papers 2
Hospital del Mar Research Institute (IMIM), Pompeu Fabra University (UPF)
Co-authored papers 2
Erasmus University Medical Center
Co-authored papers 2
Co-authored papers 2
Medical University of South Carolina
Co-authored papers 2
Co-authored papers 2
Co-authored papers 1
National Institute on Aging, National Institutes of Health
Co-authored papers 1
Co-authored papers 1
Hospital del Mar Medical Research Institute
Co-authored papers 1
Institute of Data Science, Maastricht University
Co-authored papers 1
Co-authored papers 1
Columbia Universtiy College of Physicians and Surgeons
Co-authored papers 1
Erasmus University Medical Center
Co-authored papers 1
The Hospital for Sick Children
Co-authored papers 1
Hospital del Mar Medical Research Institute (IMIM), Pompeu Fabra University
Co-authored papers 1
Swedish Toxicology Sciences Research Center, Karolinska Institutet
Co-authored papers 1
Erasmus University Medical Center
Co-authored papers 1